Bernd holds a doctorate in chemistry from the Technical University of Munich, extended by management training at the St. Gallen Business School, as well as several merger/acquisition and negotiation techniques seminars. He was responsible for several negotiations and the execution of several licences and marketing contracts. Mr Muehlenweg is co-author of more than 17 publications and 2 patents.
He is a member of the Pharma Licensing Club of Germany (Pharmalizenzclub) and the Pharma Licensing Club France. More recently, Bernd was Business Development Director for Wilex AG in Munich, where he made significant contributions to position Wilex as a leader in the market of development of therapeutic molecules and diagnostic tools in oncology. He joined Nanobiotix in 2011 where he is responsible for ensuring the sustainable growth of the Company by concluding strategic alliances with partners.